Delivery Order SPE2DB20D1051-SPE2DB24FD7JT
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,517.04 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a completion date of July 10, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $1,097.08 firm fixed price contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to the DLA Troop Support Medical program, providing a range of pharmaceutical and medical products and services to U.S. Department of...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The potential value of this contract is $5,623.10 and the period of performance runs through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This award is under an existing indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $3,276.00 Firm Fixed Price Delivery Order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of July 14, 2025 and was issued on July 11, 2025. This contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $29,072.62, is a firm fixed price delivery order for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. Amerisourcebergen Drug Corp, through its Corporate Office division, provides a range of pharmaceutical products and medical supplies to support military treatment programs and facilities....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,927.48 delivery order contract is for the supply of the prescription medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of July 17, 2025 and is a firm fixed price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The firm fixed price delivery order, valued at $3,598.68, is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award, valued at $1,545.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a performance period through April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The firm fixed price delivery order, valued at $3,345.05, is for the supply of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a period of performance through March 13, 2024 and does not include a set-aside designation. Amerisourcebergen Drug...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7JTDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,645.62, is a firm fixed price delivery order for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award has a period of performance through March 19, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/18/24 |